If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gabriella Pietra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Natural Killer Cells Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
HLA Antigens Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Cytomegalovirus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 2014 Citations
  • 24 h-Index
  • 68 Article
  • 2 Review article
  • 1 Short survey

HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition

Furfaro, A. L., Ottonello, S., Loi, G., Cossu, I., Piras, S., Spagnolo, F., Queirolo, P., Marinari, U. M., Moretta, L., Pronzato, M. A., Mingari, M. C., Pietra, G. & Nitti, M., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Heme Oxygenase-1
Melanoma
Cell Death
Down-Regulation
Natural Killer Cells
4 Citations (Scopus)

Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board

Mingari, M. C., Pietra, G. & Moretta, L., Feb 1 2019, In : Trends in Immunology. 40, 2, p. 83-85 3 p.

Research output: Contribution to journalShort survey

Anti-Idiotypic Antibodies
NK Cell Lectin-Like Receptor Subfamily C
T-Lymphocytes
Neoplasms
Cell Proliferation

Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board

Mingari, M. C., Pietra, G. & Moretta, L., Feb 2019, In : Trends in Immunology. 40, 2, p. 83-85 3 p.

Research output: Contribution to journalArticle

Anti-Idiotypic Antibodies
NK Cell Lectin-Like Receptor Subfamily C
T-Lymphocytes
Neoplasms
Cell Proliferation
1 Citation (Scopus)

Influence of Vitamin D in advanced non-small cell lung cancer patients treated with nivolumab

Cusato, J., Genova, C., Tomasello, C., Carrega, P., Ottonello, S., Pietra, G., Mingari, M. C., Cossu, I., Rijavec, E., Leggieri, A., Di Perri, G., Dal Bello, M. G., Coco, S., Boccardo, S., Ferlazzo, G., Grossi, F. & D’Avolio, A., Jan 1 2019, In : Cancers. 11, 1, 125.

Research output: Contribution to journalArticle

Open Access
Vitamin D
Non-Small Cell Lung Carcinoma
Single Nucleotide Polymorphism
Anti-Idiotypic Antibodies
nivolumab
Immunologic Monitoring
Natural Killer Cells
Neoplasms
Cell Differentiation